Early response assessment of chemoradiation can guide clinical-decision making. Volume change after chemoradiation is associated with pathological response for NSCLC. Volume change is further associated with prediction of locoregional control. Association with pathologic response is significant in the IIIa subgroup. RECIST response not associated with pathologic response or locoregional control.